MedPath

Chronic Pelvic Pain Syndrome in Males

Not Applicable
Completed
Conditions
Pelvic Pain Syndrome
Interventions
Other: EXERCISE
Other: TENS
Other: ESWT
Registration Number
NCT06369545
Lead Sponsor
Biruni University
Brief Summary

The aim of this study is to evaluate the effectiveness of ESWT (Extracorporeal Shock Wave Therapy) and TENS (Transcutaneous Electrical Nerve Stimulation) in individuals diagnosed with chronic pelvic pain syndrome and treated with medication. The study was organized as a randomized controlled trial. The sample size is 30 patients suffering from chronic pelvic pain syndrome.

Detailed Description

Volunteers who are between the ages of 20-40, diagnosed with chronic pelvic pain syndrome, and who meet the inclusion criteria will be included in the study and will be randomized into 2 groups: Group I (TENS) and Group II (ESWT).

Recruitment & Eligibility

Status
COMPLETED
Sex
Male
Target Recruitment
38
Inclusion Criteria
  1. Aged between 20-40 years old males
  2. Diagnosis of Chronic Pelvic Pain Syndrome
Exclusion Criteria
  1. Cancer

  2. Surgery related to pelvic floor

  3. Receiving drug treatment

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
GROUP I: TENSEXERCISEPHYSIOTHERAPY PROGRAM PLUS TENS
GROUP I: TENSTENSPHYSIOTHERAPY PROGRAM PLUS TENS
GROUP II: ESWTESWTPHYSIOTHERAPY PROGRAM PLUS ESWT
GROUP II: ESWTEXERCISEPHYSIOTHERAPY PROGRAM PLUS ESWT
Primary Outcome Measures
NameTimeMethod
National Institutes of Health Chronic Prostatitis Symptom Index (NIH-CPSI)baseline and immediately after the intervention

This assesses the quality of life. The index has sub dimensions(pain, urinary symptoms, quality of life impact).

The score evaluation of the pain scale is between 1 and 21 points, the score evaluation of the urination scale is between 0 and 10 points, and the score evaluation of the quality of life scale is between 0 and 12 points.

VISUAL ANALOUGE SCALEbaseline and immediately after the intervention

It evaluates pain intensity grading between 0-10. Higher score shows severe pain.

ALGOMETERbaseline and immediately after the intervention

This evaluates pain tolerance threshold of the patients.The less score shows pain intolerance.

Secondary Outcome Measures
NameTimeMethod
Hospital Anxiety and Depression Scale- HADbaseline and immediately after the intervention

This evaluates depresive symtoms of the patients.This scale is a self-rating scale. The scale is a 4-point Likert type scale consisting of 14 items in total, including anxiety and depression subscales (Aydemir, Güvenir, Küey, \& Kültür, 1997). 7 items in the scale are for anxiety and 7 items are for depression. Participants will be asked to mark each item considering the situation they have experienced in the last week. Each item contains four options. Options will be scored between 0-3 points. The lowest score for the anxiety and depression subscales is 0 and the highest score is 21 points.

Lasegue Testbaseline and immediately after the intervention

To measure flexibility of the sciatic nerve, manually.

Nottingham Health Profile-NHPbaseline and immediately after the intervention

This evaluates quality of life of the patients. The survey consists of 6 sections. These sections are pain, emotional reactions, social isolation, physical activity, energy and sleep. It consists of 38 items in total. Each section is scored between 0-100 points. 0 will be considered the best score and 100 will be considered the worst score.

Digital Muscle Testingbaseline and immediately after the intervention

To evaluate muscles's strenght using by Power Track. Higher cosre shows good strneght.

Flexibility Measurementsbaseline and immediately after the intervention

To measure flexibility of the muscles, manually. The amount of elasticity is measured and the result is recorded in cm.

ROM Assessmentsbaseline and immediately after the intervention

To measure range of motion of the joints by using goniometer.

Trial Locations

Locations (1)

Faculty of Health Sciences in Biruni University

🇹🇷

İ̇stanbul, Zeytinburnu, Turkey

© Copyright 2025. All Rights Reserved by MedPath